Patent Assignment
Reel/Frame 056284/0111
Employment Agreement
Recorded: 2021-05-13
Pages: 9
Assignor
TKACHENKO, NATALIA
Executed: 2011-04-26
Assignee
TRIMEL BIOPHARMA INC.
10 CARLSON COURT, ETOBIOCOKE, ONTARIO, M9W 6L2, CANADA
Covered Properties
(12)
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
14/215,882 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
14/536,130 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
14/753,552 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
15/045,208 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
15/284,479 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
15/599,316 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
15/856,156 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
16/044,903 →
Methods of Treating Hypogonadism with Transnasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Application:
16/275,633 →
Methods of Treating Hypogonadism with Transnasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event
Methods of Treating Hypogonadism With Transnasal Testerosterone Bio-Adhesive Gel Formulations in Male With Allergic Rhinitis, And Methods for Preventing An Allergic Rhinitis Event
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
61/802,297 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 25, 2014
From: TRIMEL BIOPHARMA SRL
To: MIDCAP FUNDING V, LLC
Reel/Frame 033416/0897 →
Assignment of Assignor's Interest
Oct 9, 2015
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036827/0897 →
Change of Name
Dec 5, 2017
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 044693/0936 →
Security Interest
Jan 24, 2018
From: ACERUS BIOPHARMA INC.
To: QUANTIUS INC.
Reel/Frame 044719/0767 →
Release of Security Interest
Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Intellectual Property Security Agreement
Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Release of Security Interest
Nov 2, 2018
From: QUANTIUS INC.
To: ACERUS PHARMACEUTICALS CORPORATION; ACERUS LABS INC.; ACERUS BIOPHARMA INC.
Reel/Frame 047399/0698 →
Assignment of Assignor's Interest
May 13, 2021
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 056233/0589 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056285/0129 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056283/0289 →
Gudaitis Declaration Supporting Chain of Title
May 13, 2021
From: TRIMEL BIOPHARMA INC.
To: ACERUS BIOPHARMA INC.
Reel/Frame 056252/0740 →
Change of Name
May 13, 2021
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 056238/0484 →
Security Interest
Dec 22, 2023
From: ACERUS BIOPHARMA INC.
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0920 →